1. Home
  2. NTRA vs RYAAY Comparison

NTRA vs RYAAY Comparison

Compare NTRA & RYAAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$212.07

Market Cap

29.1B

Sector

Health Care

ML Signal

HOLD

Logo Ryanair Holdings plc

RYAAY

Ryanair Holdings plc

HOLD

Current Price

$60.33

Market Cap

30.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
RYAAY
Founded
2003
1985
Country
United States
Ireland
Employees
N/A
25952
Industry
Medical Specialities
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
29.1B
30.7B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
RYAAY
Price
$212.07
$60.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
2
Target Price
$259.07
$78.00
AVG Volume (30 Days)
1.3M
1.3M
Earning Date
05-07-2026
05-18-2026
Dividend Yield
N/A
1.54%
EPS Growth
0.65
N/A
EPS
N/A
N/A
Revenue
$210,939,000.00
N/A
Revenue This Year
$18.08
$11.99
Revenue Next Year
$19.65
$6.32
P/E Ratio
N/A
$12.60
Revenue Growth
N/A
N/A
52 Week Low
$131.81
$53.14
52 Week High
$256.36
$74.24

Technical Indicators

Market Signals
Indicator
NTRA
RYAAY
Relative Strength Index (RSI) 51.37 56.49
Support Level $186.96 $55.43
Resistance Level $222.53 $61.70
Average True Range (ATR) 10.51 1.47
MACD 0.34 0.11
Stochastic Oscillator 51.46 70.02

Price Performance

Historical Comparison
NTRA
RYAAY

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About RYAAY Ryanair Holdings plc

Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.

Share on Social Networks: